NCT02764892View on ClinicalTrials.gov

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions
Parkinson's Disease
Interventions
DRUG

V81444

Single oral dose of V81444

All Listed Sponsors
lead

Vernalis (R&D) Ltd

INDUSTRY

NCT02764892 - A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease | Biotech Hunter | Biotech Hunter